[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$fA0wOFovlOYr6brijlxg_ZJUfWPTdmEr39ZYobFffr1o":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":11,"nonDrugCount":12,"topConditions":13,"upcomingReadouts":34,"phaseBuckets":40,"rows":47},"Bnai Zion Medical Center",[4],102,false,12,3,16438,1,80,[14,17,20,23,25,27,30,32],{"name":15,"count":16},"Adverse Anesthesia Outcome",10,{"name":18,"count":19},"Healthy",5,{"name":21,"count":22},"Pain",4,{"name":24,"count":9},"Hearing Loss",{"name":26,"count":9},"Anxiety",{"name":28,"count":29},"Child, Only",2,{"name":31,"count":29},"Heart Failure",{"name":33,"count":29},"Cesarean Section",[35],{"nctId":36,"briefTitle":37,"date":38,"intervention":39},"NCT07288021","Topical Anesthesia During Catheter Insertion for Cervical Ripening (TOLERANCE)","2026-02-28","Topical Analgesia with Lidocaine-Prilocaine cream",[41,42,43,44,45,46],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[48,72,100,118,144,168,193,218,243,267,293,317,353,386,411,429,455,480,498,523,546,569,593],{"intervention":39,"totalTrials":11,"cells":49},{"EARLY_PHASE1":50,"PHASE1":53,"PHASE2":55,"PHASE3":57,"PHASE4":59,"NA":70},{"trials":51,"activeCount":52},[],0,{"trials":54,"activeCount":52},[],{"trials":56,"activeCount":52},[],{"trials":58,"activeCount":52},[],{"trials":60,"activeCount":11,"soonestReadout":38},[61],{"nctId":36,"briefTitle":37,"status":62,"phases":63,"primaryCompletion":38,"completion":64,"start":65,"enrollment":66,"conditions":67,"interventions":69},"RECRUITING",[45],"2026-07-01","2024-02-05",200,[68],"Labor, Induced",[39],{"trials":71,"activeCount":52},[],{"intervention":73,"totalTrials":11,"cells":74},"Bupivacaine and Fentanyl",{"EARLY_PHASE1":75,"PHASE1":77,"PHASE2":79,"PHASE3":81,"PHASE4":83,"NA":98},{"trials":76,"activeCount":52},[],{"trials":78,"activeCount":52},[],{"trials":80,"activeCount":52},[],{"trials":82,"activeCount":52},[],{"trials":84,"activeCount":52},[85],{"nctId":86,"briefTitle":87,"status":88,"phases":89,"primaryCompletion":90,"completion":90,"start":91,"enrollment":92,"conditions":93,"interventions":96},"NCT01303731","Comparison of Standard and Minidose Spinal Anesthesia for Cesarean Section Operation Using Marcaine Spinal 0.5% Heavy","UNKNOWN",[45],"2012-01","2011-02",100,[33,94,95],"Anesthesia, Spinal","Local Anaesthetics Causing Adverse Effects in Therapeutic Use",[73,97],"Bupivacaine",{"trials":99,"activeCount":52},[],{"intervention":97,"totalTrials":11,"cells":101},{"EARLY_PHASE1":102,"PHASE1":104,"PHASE2":106,"PHASE3":108,"PHASE4":110,"NA":116},{"trials":103,"activeCount":52},[],{"trials":105,"activeCount":52},[],{"trials":107,"activeCount":52},[],{"trials":109,"activeCount":52},[],{"trials":111,"activeCount":52},[112],{"nctId":86,"briefTitle":87,"status":88,"phases":113,"primaryCompletion":90,"completion":90,"start":91,"enrollment":92,"conditions":114,"interventions":115},[45],[33,94,95],[73,97],{"trials":117,"activeCount":52},[],{"intervention":119,"totalTrials":11,"cells":120},"Pamidronate",{"EARLY_PHASE1":121,"PHASE1":123,"PHASE2":125,"PHASE3":127,"PHASE4":129,"NA":142},{"trials":122,"activeCount":52},[],{"trials":124,"activeCount":52},[],{"trials":126,"activeCount":52},[],{"trials":128,"activeCount":52},[],{"trials":130,"activeCount":52},[131],{"nctId":132,"briefTitle":133,"status":88,"phases":134,"primaryCompletion":135,"completion":136,"start":137,"enrollment":138,"conditions":139,"interventions":141},"NCT02313727","Combined Treatment With TNF Inhibitor and Pamidronate in AS Patients: Effect on the Radiographic Progression",[45],"2017-06","2017-09","2014-12",30,[140],"Ankylosing Spondylitis",[119],{"trials":143,"activeCount":52},[],{"intervention":145,"totalTrials":11,"cells":146},"beta carotene from Dunaliella algae",{"EARLY_PHASE1":147,"PHASE1":149,"PHASE2":151,"PHASE3":153,"PHASE4":164,"NA":166},{"trials":148,"activeCount":52},[],{"trials":150,"activeCount":52},[],{"trials":152,"activeCount":52},[],{"trials":154,"activeCount":52},[155],{"nctId":156,"briefTitle":157,"status":88,"phases":158,"start":159,"enrollment":160,"conditions":161,"interventions":163},"NCT00275418","Beta Carotene From Natural Source for Patients With Non-Active Crohn's Disease",[44],"2002-07",300,[162],"Crohn's Disease",[145],{"trials":165,"activeCount":52},[],{"trials":167,"activeCount":52},[],{"intervention":169,"totalTrials":11,"cells":170},"Experimental group: Budicort by Inhalation",{"EARLY_PHASE1":171,"PHASE1":173,"PHASE2":175,"PHASE3":187,"PHASE4":189,"NA":191},{"trials":172,"activeCount":52},[],{"trials":174,"activeCount":52},[],{"trials":176,"activeCount":52},[177],{"nctId":178,"briefTitle":179,"status":88,"phases":180,"primaryCompletion":181,"start":182,"enrollment":183,"conditions":184,"interventions":186},"NCT01858129","Inhaled Corticosteroids for the Treatment of Transient Tachypnea of the Newborn",[43],"2015-05","2012-03",56,[185],"Transient Tachypnea of the Newborn",[169],{"trials":188,"activeCount":52},[],{"trials":190,"activeCount":52},[],{"trials":192,"activeCount":52},[],{"intervention":194,"totalTrials":11,"cells":195},"Inhaled extra-fine hydrofluoalkane-beclomethasone",{"EARLY_PHASE1":196,"PHASE1":198,"PHASE2":200,"PHASE3":212,"PHASE4":214,"NA":216},{"trials":197,"activeCount":52},[],{"trials":199,"activeCount":52},[],{"trials":201,"activeCount":52},[202],{"nctId":203,"briefTitle":204,"status":88,"phases":205,"primaryCompletion":206,"completion":206,"start":207,"enrollment":208,"conditions":209,"interventions":211},"NCT01373008","Inhaled Extra-fine Hydrofluoalkane-beclomethasone (QVAR) in Premature Infants With Bronchopulmonary Dysplasia (BPD)",[43],"2016-06","2011-06",60,[210],"Bronchopulmonary Dysplasia",[194],{"trials":213,"activeCount":52},[],{"trials":215,"activeCount":52},[],{"trials":217,"activeCount":52},[],{"intervention":219,"totalTrials":11,"cells":220},"Ambrisentan 10 MG",{"EARLY_PHASE1":221,"PHASE1":223,"PHASE2":225,"PHASE3":237,"PHASE4":239,"NA":241},{"trials":222,"activeCount":52},[],{"trials":224,"activeCount":52},[],{"trials":226,"activeCount":52},[227],{"nctId":228,"briefTitle":229,"status":88,"phases":230,"primaryCompletion":231,"completion":232,"start":233,"enrollment":138,"conditions":234,"interventions":236},"NCT04450095","Effects of Endothelin Receptor Antagonist on Ischemic Kidney Injury During Nephron Sparing Surgery",[43],"2020-02-01","2020-10-01","2018-10-11",[235],"Kidney Failure, Acute",[219],{"trials":238,"activeCount":52},[],{"trials":240,"activeCount":52},[],{"trials":242,"activeCount":52},[],{"intervention":244,"totalTrials":11,"cells":245},"omega-3 fatty acid",{"EARLY_PHASE1":246,"PHASE1":248,"PHASE2":250,"PHASE3":261,"PHASE4":263,"NA":265},{"trials":247,"activeCount":52},[],{"trials":249,"activeCount":52},[],{"trials":251,"activeCount":52},[252],{"nctId":253,"briefTitle":254,"status":88,"phases":255,"completion":256,"start":257,"enrollment":208,"conditions":258,"interventions":260},"NCT00408304","Prevention of Depression With Omega-3 Fatty Acids in Chronic Carriers of Hepatitis C Treated With Interferon Alpha.",[43],"2007-12","2006-12",[259],"Chronic Hepatitis C",[244],{"trials":262,"activeCount":52},[],{"trials":264,"activeCount":52},[],{"trials":266,"activeCount":52},[],{"intervention":268,"totalTrials":11,"cells":269},"Obinutuzumab with Ibrutinib and Venetoclax",{"EARLY_PHASE1":270,"PHASE1":272,"PHASE2":274,"PHASE3":287,"PHASE4":289,"NA":291},{"trials":271,"activeCount":52},[],{"trials":273,"activeCount":52},[],{"trials":275,"activeCount":52},[276],{"nctId":277,"briefTitle":278,"status":279,"phases":280,"primaryCompletion":281,"completion":282,"start":283,"enrollment":8,"conditions":284,"interventions":286},"NCT04939363","A Study to Evaluate Efficacy & Safety of Obinutuzumab, Ibrutinib, and Venetoclax in Richter's Syndrome;","COMPLETED",[43],"2024-10-09","2024-12-04","2021-08-08",[285],"Richter's Syndrome",[268],{"trials":288,"activeCount":52},[],{"trials":290,"activeCount":52},[],{"trials":292,"activeCount":52},[],{"intervention":294,"totalTrials":11,"cells":295},"Inhaled Furosemide vs Placebo",{"EARLY_PHASE1":296,"PHASE1":298,"PHASE2":309,"PHASE3":311,"PHASE4":313,"NA":315},{"trials":297,"activeCount":52},[],{"trials":299,"activeCount":52},[300],{"nctId":301,"briefTitle":302,"status":279,"phases":303,"completion":304,"start":305,"conditions":306,"interventions":308},"NCT00261937","Inhaled Furosemide Versus Placebo for Acute Viral Bronchiolitis in Hospitalized Infants",[42],"2006-04","2005-12",[307],"Bronchiolitis",[294],{"trials":310,"activeCount":52},[],{"trials":312,"activeCount":52},[],{"trials":314,"activeCount":52},[],{"trials":316,"activeCount":52},[],{"intervention":318,"totalTrials":29,"cells":319},"Lactulose",{"EARLY_PHASE1":320,"PHASE1":322,"PHASE2":324,"PHASE3":338,"PHASE4":340,"NA":342},{"trials":321,"activeCount":52},[],{"trials":323,"activeCount":52},[],{"trials":325,"activeCount":52},[326],{"nctId":327,"briefTitle":328,"status":279,"phases":329,"primaryCompletion":330,"completion":331,"start":332,"enrollment":333,"conditions":334,"interventions":337},"NCT00616876","Lactulose Supplementation in Premature Infants",[43],"2006-08","2007-01","2005-02",28,[335,336],"Necrotizing Enterocolitis","Sepsis",[318],{"trials":339,"activeCount":52},[],{"trials":341,"activeCount":52},[],{"trials":343,"activeCount":52},[344],{"nctId":345,"briefTitle":346,"status":88,"phases":347,"completion":331,"start":348,"enrollment":92,"conditions":349,"interventions":351},"NCT00273949","Lactulose for the Prevention of Nosocomial Infections in Children",[46],"2006-01",[350],"Nosocomial Infection",[352],"lactulose",{"intervention":354,"totalTrials":29,"cells":355},"Paracetamol",{"EARLY_PHASE1":356,"PHASE1":358,"PHASE2":360,"PHASE3":362,"PHASE4":364,"NA":366},{"trials":357,"activeCount":52},[],{"trials":359,"activeCount":52},[],{"trials":361,"activeCount":52},[],{"trials":363,"activeCount":52},[],{"trials":365,"activeCount":52},[],{"trials":367,"activeCount":52},[368,377],{"nctId":369,"briefTitle":370,"status":88,"phases":371,"primaryCompletion":135,"completion":372,"start":373,"enrollment":208,"conditions":374,"interventions":376},"NCT03060265","Protective Analgesia in Caesarean Section Using Intravenous Paracetamol",[46],"2017-12","2017-03",[375],"Analgesia",[354],{"nctId":378,"briefTitle":379,"status":279,"phases":380,"primaryCompletion":381,"completion":382,"start":381,"enrollment":383,"conditions":384,"interventions":385},"NCT02884921","Preemptive Analgesia Using Intravenous Paracetamol",[46],"2015-04","2016-08",87,[15],[354,354],{"intervention":387,"totalTrials":11,"cells":388},"Colchicine",{"EARLY_PHASE1":389,"PHASE1":391,"PHASE2":393,"PHASE3":395,"PHASE4":397,"NA":399},{"trials":390,"activeCount":52},[],{"trials":392,"activeCount":52},[],{"trials":394,"activeCount":52},[],{"trials":396,"activeCount":52},[],{"trials":398,"activeCount":52},[],{"trials":400,"activeCount":52},[401],{"nctId":402,"briefTitle":403,"status":88,"phases":404,"primaryCompletion":405,"completion":405,"start":406,"enrollment":12,"conditions":407,"interventions":409},"NCT00983177","Colchicine Treatment for Chronic Shoulder Pain Related to Calcific Tendonitis",[46],"2011-10","2010-03",[408],"Calcific Tendonitis",[387,410],"lactose",{"intervention":410,"totalTrials":11,"cells":412},{"EARLY_PHASE1":413,"PHASE1":415,"PHASE2":417,"PHASE3":419,"PHASE4":421,"NA":423},{"trials":414,"activeCount":52},[],{"trials":416,"activeCount":52},[],{"trials":418,"activeCount":52},[],{"trials":420,"activeCount":52},[],{"trials":422,"activeCount":52},[],{"trials":424,"activeCount":52},[425],{"nctId":402,"briefTitle":403,"status":88,"phases":426,"primaryCompletion":405,"completion":405,"start":406,"enrollment":12,"conditions":427,"interventions":428},[46],[408],[387,410],{"intervention":430,"totalTrials":11,"cells":431},"Misoprostol Oral",{"EARLY_PHASE1":432,"PHASE1":434,"PHASE2":436,"PHASE3":438,"PHASE4":440,"NA":442},{"trials":433,"activeCount":52},[],{"trials":435,"activeCount":52},[],{"trials":437,"activeCount":52},[],{"trials":439,"activeCount":52},[],{"trials":441,"activeCount":52},[],{"trials":443,"activeCount":52},[444],{"nctId":445,"briefTitle":446,"status":447,"phases":448,"primaryCompletion":449,"completion":449,"start":450,"enrollment":451,"conditions":452,"interventions":454},"NCT03866772","Labor Induction With Double Balloon Device, Oral Misoprostol and Concomitant Use of Both","TERMINATED",[46],"2023-09-24","2019-06-01",250,[453],"Pregnancy Related",[430],{"intervention":456,"totalTrials":11,"cells":457},"Betamethasone",{"EARLY_PHASE1":458,"PHASE1":460,"PHASE2":462,"PHASE3":464,"PHASE4":466,"NA":468},{"trials":459,"activeCount":52},[],{"trials":461,"activeCount":52},[],{"trials":463,"activeCount":52},[],{"trials":465,"activeCount":52},[],{"trials":467,"activeCount":52},[],{"trials":469,"activeCount":52},[470],{"nctId":471,"briefTitle":472,"status":88,"phases":473,"primaryCompletion":474,"completion":182,"start":406,"enrollment":475,"conditions":476,"interventions":478},"NCT00982332","Efficacy of Micro-Pulse Steroid Therapy as Induction Therapy in Patients With Polymyalgia Rheumatica",[46],"2011-09",20,[477],"Polymyalgia Rheumatica",[456,479],"isotonic sodium chloride solution",{"intervention":479,"totalTrials":11,"cells":481},{"EARLY_PHASE1":482,"PHASE1":484,"PHASE2":486,"PHASE3":488,"PHASE4":490,"NA":492},{"trials":483,"activeCount":52},[],{"trials":485,"activeCount":52},[],{"trials":487,"activeCount":52},[],{"trials":489,"activeCount":52},[],{"trials":491,"activeCount":52},[],{"trials":493,"activeCount":52},[494],{"nctId":471,"briefTitle":472,"status":88,"phases":495,"primaryCompletion":474,"completion":182,"start":406,"enrollment":475,"conditions":496,"interventions":497},[46],[477],[456,479],{"intervention":499,"totalTrials":11,"cells":500},"Ibuprofen",{"EARLY_PHASE1":501,"PHASE1":503,"PHASE2":505,"PHASE3":507,"PHASE4":509,"NA":511},{"trials":502,"activeCount":52},[],{"trials":504,"activeCount":52},[],{"trials":506,"activeCount":52},[],{"trials":508,"activeCount":52},[],{"trials":510,"activeCount":52},[],{"trials":512,"activeCount":52},[513],{"nctId":514,"briefTitle":515,"status":88,"phases":516,"primaryCompletion":517,"completion":517,"start":518,"enrollment":519,"conditions":520,"interventions":522},"NCT05048914","Migraine Abortive Treatment",[],"2022-01-01","2019-09-03",50,[521],"Migraine Disorders",[499],{"intervention":524,"totalTrials":11,"cells":525},"Etoricoxib",{"EARLY_PHASE1":526,"PHASE1":528,"PHASE2":530,"PHASE3":532,"PHASE4":534,"NA":536},{"trials":527,"activeCount":52},[],{"trials":529,"activeCount":52},[],{"trials":531,"activeCount":52},[],{"trials":533,"activeCount":52},[],{"trials":535,"activeCount":52},[],{"trials":537,"activeCount":52},[538],{"nctId":539,"briefTitle":540,"status":279,"phases":541,"primaryCompletion":542,"completion":543,"start":542,"enrollment":208,"conditions":544,"interventions":545},"NCT02884986","Analgesia in Inguinal Hernia Repair Using a Cyclooxygenase-2-specific Inhibitor",[46],"2015-01","2016-01",[15],[524],{"intervention":547,"totalTrials":11,"cells":548},"Naproxen Tramadol",{"EARLY_PHASE1":549,"PHASE1":551,"PHASE2":553,"PHASE3":555,"PHASE4":557,"NA":559},{"trials":550,"activeCount":52},[],{"trials":552,"activeCount":52},[],{"trials":554,"activeCount":52},[],{"trials":556,"activeCount":52},[],{"trials":558,"activeCount":52},[],{"trials":560,"activeCount":52},[561],{"nctId":562,"briefTitle":563,"status":279,"phases":564,"primaryCompletion":565,"completion":565,"start":330,"enrollment":566,"conditions":567,"interventions":568},"NCT01165814","Naproxen Versus Tramadol for Post Cesarean Pain Control",[46],"2009-03",120,[21,33],[547],{"intervention":570,"totalTrials":11,"cells":571},"Nitrous Oxide",{"EARLY_PHASE1":572,"PHASE1":574,"PHASE2":576,"PHASE3":578,"PHASE4":580,"NA":582},{"trials":573,"activeCount":52},[],{"trials":575,"activeCount":52},[],{"trials":577,"activeCount":52},[],{"trials":579,"activeCount":52},[],{"trials":581,"activeCount":52},[],{"trials":583,"activeCount":52},[584],{"nctId":585,"briefTitle":586,"status":88,"phases":587,"primaryCompletion":588,"completion":589,"start":590,"enrollment":138,"conditions":591,"interventions":592},"NCT02886351","High-Concentration Nitrous Oxide for Dental Procedural Sedation in Children",[46],"2018-01","2018-06","2017-01",[26],[570],{"intervention":594,"totalTrials":11,"cells":595},"Ondansetron",{"EARLY_PHASE1":596,"PHASE1":598,"PHASE2":600,"PHASE3":602,"PHASE4":604,"NA":606},{"trials":597,"activeCount":52},[],{"trials":599,"activeCount":52},[],{"trials":601,"activeCount":52},[],{"trials":603,"activeCount":52},[],{"trials":605,"activeCount":52},[],{"trials":607,"activeCount":52},[608],{"nctId":609,"briefTitle":610,"status":88,"phases":611,"primaryCompletion":612,"completion":613,"start":614,"enrollment":92,"conditions":615,"interventions":616},"NCT02883192","The Effect of Preventive Use of Ondansetron in the Cesarean Section Under Spinal Anesthesia",[46],"2016-10","2016-12","2016-02",[15],[594]]